Results have shown significant reductions in body weight, body mass index (BMI), and waist circumference among participants compared to a placebo group
It also documents that patients received and understood patient information leaflets and safety warnings-particularly the Novo Nordisk safety information about black triangle monitoring status and the Yellow Card Scheme for adverse event reporting
The biomarkers to watch when you're on a GLP-1 Most people on a GLP-1 track one number: their weight on the scale
What does this mean for patients & our practice GLP-1 treatment with semaglutide can offer cardiovascular protection beyond pure weight loss, a potentially valuable tool in treating overweight, together with established cardiovascular disease
When to talk with a doctor about supplements on Ozempic or a GLP-1 Before starting a GLP-1, it's worth talking to your care provider about getting baseline blood work done it can "help identify nutrient gaps early, before they become symptomatic," Pratt says
